Decipher Labs Limited (BOM:524752)
India · Delayed Price · Currency is INR 6.00
-0.20 (-3.23%)
At close: Sep 25, 2026
Decipher Labs Revenue
Decipher Labs had revenue of 25.11M INR in the quarter ending June 30, 2026, a decrease of -14.43%. This brings the company's revenue in the last twelve months to 138.51M, down -28.11% year-over-year. In the fiscal year ending March 31, 2026, Decipher Labs had annual revenue of 140.54M, down -37.85%.
Revenue (ttm)
138.51M
Revenue Growth
-28.11%
P/S Ratio
0.44
Revenue / Employee
138.51M
Employees
1
Market Cap
60.60M
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2026 | 140.54M | -85.59M | -37.85% |
| Mar 31, 2025 | 226.13M | -132.66M | -36.97% |
| Mar 31, 2024 | 358.79M | -170.38M | -32.20% |
| Mar 31, 2023 | 529.16M | -124.06M | -18.99% |
| Mar 31, 2022 | 653.22M | 97.60M | 17.57% |
| Mar 31, 2021 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Vivanza Biosciences | 1.17B |
| Beryl Drugs | 213.23M |
| Fabino Enterprises | 208.42M |
| Brawn Biotech | 172.59M |
| Unjha Formulations | 152.79M |
| Desh Rakshak Aushdhalaya | 66.33M |
| Ganga Pharmaceuticals | 28.28M |
| Emmessar Biotech & Nutrition | 23.78M |